help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 25, 2005
Endocrinology, doi:10.1210/en.2005-0591
A more recent version of this article appeared on December 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
146/12/5380    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, T.
Right arrow Articles by Michael, L. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, T.
Right arrow Articles by Michael, L. F.

Submitted on May 16, 2005
Accepted on August 15, 2005

Hepatic peroxisomal fatty acid beta oxidation is regulated by liver X receptor {alpha} (LXR{alpha})

Tonghuan Hu, Patricia Foxworthy, Angela Siesky, James V. Ficorilli, Hong Gao, Shuyu Li, Michael Christe, Timothy Ryan, Guoqing Cao, Patrick Eacho, M. Dodson Michael, and Laura F. Michael*

Lilly Research Laboratories, Departments of Cardiovascular Research, Endocrinology, Toxicology, Integrative Biology, Eli Lilly and Company, Indianapolis, IN 46285

* To whom correspondence should be addressed. E-mail: laura_michael{at}lilly.com.

Peroxisomes are the exclusive site for the {beta}-oxidation of very-long-chain fatty acids of greater than 20 carbons in length (VLCFAs). Although the bulk of dietary long chain fatty acids are oxidized in the mitochondria, VLCFAs cannot be catabolized in mitochondria and must be shortened first by peroxisomal {beta}-oxidation. The regulation of peroxisomal, mitochondrial and microsomal fatty acid oxidation systems in liver is mediated principally by PPAR{alpha}. In this study, we provide evidence that the liver X receptor (LXR) regulates expression of the genetic program for peroxisomal {beta}-oxidation in liver. The genes encoding the three enzymes of the classic peroxisomal {beta}-oxidation cycle--acyl CoA oxidase, enoyl-CoA hydratase/liter-3-hydroxyacyl-CoA dehydrogenase, and 3-ketoacyl-CoA thiolase--are activated by the LXR ligand, T0901317. Accordingly, administration of T0901317 in mice promoted a dose-dependent and greater than 2-fold increase in the rate of peroxisomal {beta}-oxidation in the liver. The LXR effect is independent of PPAR{alpha} since T0901317-induced peroxisomal {beta}-oxidation in liver of PPAR{alpha} null mice. Interestingly, T0901317-induced peroxisomal {beta}-oxidation is dependent on the LXR{alpha} isoform, but not the LXR{beta} isoform. We propose that induction of peroxisomal {beta}-oxidation by LXR agonists may serve as a counter-regulatory mechanism for responding to hypertriglyceridemia and liver steatosis that is promoted by potent LXR agonists in vivo; however, further studies are warranted.




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
G. Musso, R. Gambino, F. De Michieli, G. Biroli, A. Premoli, G. Pagano, S. Bo, M. Durazzo, and M. Cassader
Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 661 - 671.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society